lifestyle.capitolhilltimes.com

Author: Vanderbilt Report and Artelo Biosciences

UPDATE – The Vanderbilt Report Initiates Coverage of RenX Enterprises Corp. – 2025 Results Beat Guidance on Every Material Metric

April 14, 2026
RenX Enterprises Reports Record Full-Year Results as Microtec UTM 1200 Turbo Mill Ships from Germany

April 14, 2026
RenX Enterprises Executes 1-for-20 Reverse Split, Creating One of Nasdaq’s Tightest Floats Amid Accelerating Revenue Growth

March 27, 2026
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

March 25, 2026
Waste-to-Value: Building Florida’s Premier Biomass Platform

March 23, 2026
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

March 18, 2026